MENU
SAGE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Sage Therapeutics (SAGE) Earnings Date & Reports

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines... Show more

A.I. Advisor
published Earnings

SAGE is expected to report earnings to fall 4.20% to -96 cents per share on August 05

Sage Therapeutics SAGE Stock Earnings Reports
Q2'25
Est.
$-0.97
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.06
Q3'24
Beat
by $0.01
Q2'24
Missed
by $0.06
The last earnings report on April 29 showed earnings per share of -100 cents, missing the estimate of -99 cents. With 877.86K shares outstanding, the current market capitalization sits at 413.92M.
View a ticker or compare two or three
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutics and medicines for central nervous system disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
215 First Street
Phone
+1 617 299-8380
Employees
487
Web
https://www.sagerx.com